Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Pharma Grade Calcium Sulphate Market Growth Potential: How Will Market Size Shift Through 2030?
Recent years have seen robust growth in the pharma grade calcium sulphate market size. The market is projected to expand from $0.96 billion in 2025 to $1.04 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. Historically, this growth has been driven by factors such as an increase in pharmaceutical manufacturing, a greater demand for solid dosage forms, the expansion of generic drug production, the increasing adoption of calcium-based excipients, and a stronger regulatory focus on excipient quality.
The pharma grade calcium sulphate market is anticipated to show significant expansion in the upcoming years. It is projected to attain a size of $1.44 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. This growth during the forecast period can be attributed to factors such as the increase in global drug production, the growing application of high-performance excipients, an escalating demand for consistent formulation quality, the enlargement of nutraceutical manufacturing, and advancements in excipient processing. Prominent trends expected in this period include an increasing requirement for high-purity pharmaceutical excipients, their expanding use in tablet and capsule formulations, rising adoption in calcium supplement manufacturing, the broadening of quality-controlled excipient production, and an amplified focus on materials that comply with regulatory standards.
Get A Free Sample Report With In-Depth Market Insights:
Pharma Grade Calcium Sulphate Market Growth Momentum: What Factors Are Shaping Demand?
The increasing need for pharmaceutical products is projected to boost expansion in the pharma grade calcium sulphate market. Pharmaceuticals are defined as medicines and drugs created, produced, and utilized for the diagnosis, treatment, or prevention of illnesses in both humans and animals. This escalating demand for pharmaceuticals largely stems from the increasing incidence of chronic ailments, compelling a greater number of people to rely on extended medication regimens for managing conditions like diabetes, cardiovascular disorders, and cancer. As a high-purity excipient, pharma grade calcium sulphate improves pharmaceutical formulations by guaranteeing uniform tablet hardness, overall stability, and the regulated release of active components. For example, data from Eurostat, the European Union’s official statistical agency based in Luxembourg, revealed in April 2024 that the EU’s imports of medicinal and pharmaceutical goods rose by 6.1% in 2023, reaching a total of $137.4 billion (€119 billion) when compared to the prior year. Over the identical timeframe, EU exports amounted to $319.2 billion (€277 billion), leading to a significant trade surplus of $182.0 billion (€158 billion). Consequently, the increasing need for pharmaceuticals is a key factor propelling the expansion of the pharma grade calcium sulphate market.
Pharma Grade Calcium Sulphate Market Segmentation: How Does The Market Break Down By Category?
The pharma grade calcium sulphate market covered in this report is segmented –
1) By Type: Calcium Sulphate Dihydrate, Calcium Sulphate Hemihydrate, Calcium Sulphate Anhydrite
2) By Application: Pharmaceutical Excipients, Binders In Tablet Formulations, Calcium Supplements, Diagnostic Agents
3) By Distribution Channel: Direct Distribution, Online Distribution, Wholesale Distribution, Retail Distribution
Subsegments:
1) By Calcium Sulphate Dihydrate: Fine Powder, Granular Form, Micronized Grade
2) By Calcium Sulphate Hemihydrate: Alpha Hemihydrate, Beta Hemihydrate, High Purity Hemihydrate
3) By Calcium Sulphate Anhydrite: Natural Anhydrite, Synthetic Anhydrite, High-Density Anhydrite
Pharma Grade Calcium Sulphate Market Trends Redefining Industry Growth
Leading companies in the pharma grade calcium sulphate market are concentrating on creating novel products, leveraging synthetic medical-grade bassanite to improve the purity and consistency of their calcium sulphate offerings. This synthetic medical-grade bassanite, identified as CaSO₄·0.5H₂O and characterized by its high purity and partial dehydration, facilitates the production of pharma-grade calcium sulphate by supplying a uniform, uncontaminated material that adheres to rigorous regulatory requirements for medical and pharmaceutical purposes. An example of this trend is the launch in February 2025 by Sree Chitra Tirunal Institute for Medical Sciences & Technology, an Indian medical institution, of Caspro & Bonyx. These are pioneering drug-eluting bone graft products, also developed with synthetic medical-grade bassanite to guarantee elevated purity, biocompatibility, and regulated drug delivery for sophisticated orthopedic uses. Caspro itself is a self-hardening, malleable bone cement composed of calcium sulfate hemihydrate fortified with phosphate ions, making it suitable for filling bone defects and releasing drugs at the implantation site for over 21 days. Bonyx, on the other hand, comprises osteoconductive bioceramic beads that can be vacuum-filled with antibiotics or other liquid medications, allowing for sustained drug release for more than 30 days. Such products signify a substantial advancement in localized treatment for bone infections and regeneration, illustrating the potential of pharma-grade calcium sulphate in advanced biomedical solutions that comply with strict international benchmarks.
Pharma Grade Calcium Sulphate Market Competitive Overview And Top Companies
Major companies operating in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Merck KGaA, Honeywell International Inc., Avantor Inc., Spectrum Chemical Manufacturing Corp., MP Biomedicals LLC, Anhui Sunhere Pharmaceutical Excipients, Huzhou Zhanwang Pharmaceutical Co. Ltd., Loba Chemie Pvt. Ltd., SRL Chemical, GFS Chemicals Inc., American Elements, Junsei Chemical Co. Ltd., Tokyo Chemical Industry Co. Ltd., Fagron N.V., Mallinckrodt Pharmaceuticals, Ashland Global Holdings Inc., JRS Pharma, DFE Pharma, Roquette Frères
View The Full Pharma Grade Calcium Sulphate Market Report:
Pharma Grade Calcium Sulphate Market Geographic Distribution And Regional Opportunities
North America was the largest region in the pharma grade calcium sulphate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma grade calcium sulphate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model